Document is current
Any future updates will be listed below
-
Authors
Raccosta, Laura
Marinozzi, Maura https://orcid.org/0000-0001-5994-9390
Costantini, Susan
Maggioni, Daniela
Ferreira, Lorena Maria
Corna, Gianfranca
Zordan, Paola
Sorice, Angela
Farinello, Diego
Bianchessi, Silvia
Riba, Michela
Lazarevic, Dejan https://orcid.org/0000-0003-4527-290X
Provero, Paolo
Mack, Matthias https://orcid.org/0000-0002-3157-7262
Bondanza, Attilio
Nalvarte, Ivan https://orcid.org/0000-0001-6828-2583
Gustafsson, J-A
Ranzani, Valeria
De Sanctis, Francesco
Ugel, Stefano https://orcid.org/0000-0002-6639-7608
Baron, Silvère
Lobaccaro, Jean-Marc A.
Pontini, Lorenzo
Pacciarini, Manuela
Traversari, Catia
Pagani, Massimiliano
Bronte, Vincenzo https://orcid.org/0000-0002-3741-5141
Sitia, Giovanni https://orcid.org/0000-0003-1024-9128
Antonson, Per
Brendolan, Andrea
Budillon, Alfredo https://orcid.org/0000-0002-6330-6053
Russo, Vincenzo https://orcid.org/0000-0003-1592-5041
-
Funding
Funding for this research was provided by:
Fondazione Umberto Veronesi
Associazione Italiana per la Ricerca sul Cancro (IG 19016)
Associazione Italiana per la Ricerca sul Cancro (IG 15452)
Associazione Italiana per la Ricerca sul Cancro (IG 26305)
Associazione Italiana per la Ricerca sul Cancro (IG 22737)
- License Information
-
More Information
Article History
Received: 1 December 2022
Revised: 23 January 2023
Accepted: 25 January 2023
First Online: 15 February 2023
Competing interests
: Attilio Bondanza is an employee of AstraZeneca. No other potential conflicts of interest were disclosed. There are patent applications pending related to this work.
